https://news1global.com/economy/article/444178/News1en2026-11-02T18:43:03+09:00GM’s New Hybrid SUVs: Will They Outperform Hyundai’s Palisade and Kia’s Telluride? https://news1global.com/lifestyle/article/444176/News1en2026-11-02T18:39:42+09:002026 KBO Korean Series: KT Wiz vs. Samsung Lions – Who Will Come Out on Top? https://news1global.com/economy/article/444174/News1en2026-11-02T18:35:29+09:00Is Now the Time to Invest? KOSPI Surges Past 5800 Amid Semiconductor Recovery https://news1global.com/health/article/444172/News1en2026-11-02T18:31:35+09:00IKS014 vs. Enhertu: Can This New HER2 ADC Drug Revolutionize Breast Cancer Treatment? https://news1global.com/health/article/444170/News1en2026-11-02T18:28:51+09:00IMB-105: The Next Breakthrough in Autoimmune Disease Treatment? https://news1global.com/health/article/444168/News1en2026-11-02T18:26:01+09:00How MEDTIS is Revolutionizing Remote Healthcare in Asia: Insights from Health On Cloud’s CEO https://news1global.com/health/article/444166/News1en2026-11-02T18:24:18+09:00Budget Cuts Threaten Custom Rare Disease Treatments for Children: What’s Next for ARPA-H? https://news1global.com/health/article/444164/News1en2026-11-02T18:21:55+09:00L&C Bio’s Re2O Set to Transform Thailand’s Beauty Market: What You Need to Know https://news1global.com/health/article/444162/News1en2026-11-02T18:18:26+09:00Samsung Bioepis Launches SB27: Will This Keytruda Biosimilar Transform Cancer Treatment in the U.S.? https://news1global.com/health/article/444160/News1en2026-11-02T18:16:16+09:00Curocell’s RIMQARTO: The Secret Behind Its Expanded Second-Line Treatment Indication https://news1global.com/health/article/444158/News1en2026-11-02T13:01:42+09:00Leading Fertility Experts to Gather in Busan as Patients Seek Answers on Treatment Options https://news1global.com/health/article/444156/News1en2026-11-02T13:01:19+09:00Daewoong Pharmaceutical Targets Global Market With Long-Acting Injection and Patch Technologies https://news1global.com/health/article/444154/News1en2026-11-02T12:58:53+09:00PRBom and MSD Korea Place Third in Global PR Awards for HPV Prevention Campaign https://news1global.com/health/article/444153/News1en2026-11-02T12:58:44+09:00Celltrion Pharm Launches Prefilled-Syringe Version of Yuflyma in South Korea, Strengthening Price Competitiveness https://news1global.com/health/article/444151/News1en2026-11-02T12:58:31+09:00Konkuk University Medical Team Surpasses 6,000 Microvascular Decompression Surgeries